Global Clinical Software Market

Clinical Software Comprehensive Study by Application (Hospitals, Clinics, Medical Research Centres, Others), End-Use Industries (Pharmaceutical, Biotechnology, Healthcare, Others), Deployment (On-Cloud, On-Premises), Delivery (Web-Based, Licensed Enterprise, Software as a Service (SAAS)) Players and Region - Global Market Outlook to 2026

Clinical Software Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Clinical Software Market Overview:
Clinical software is specialized software used by healthcare providers to manage their patient's workflow. COVID-19 pandemic has disrupted global markets, industries, hospitals, and sectors. That affects staff shortage, and supply chain disruptions. Clinical software improved new technologies such as cloud-based solutions, biometric devices, Artificial Intelligence (AI), advanced analytics, connected devices, and wearables become more widely adopted.

Growth Drivers
  • Rising prevalence of infectious, chronic, and rare diseases
  • Increasing demand for remote monitoring

Roadblocks
  • High cost
  • Lack of technical competence among healthcare sectors

Opportunities
  • Pharmaceutical and healthcare industry are increasingly focusing on clinical software that drives clinical outcome which improves effectiveness during the forecast period
  • Innovative technologies such as remote monitoring, remote collaboration, automated data collection and analysis, and others

Challenges
  • Delays caused by disconnected systems, redundant workflows, and manual data re-entry


Competitive Landscape:
Companies in the market are concentrating on healthcare services and software. North America is expected largest region for clinical software due to increasing aging populations, increasing prevalence of chronic and infectious diseases, and rising expenditures on research and development sectors. The rapid adoption of digital technologies, increasing preference for digital software, and rising number of research activities drive the market for this region.
Some of the key players profiled in the report are Medidata Solutions Inc. (United States), International Machine Business Corporation (IBM) (United States), Oracle Corporation (India), Parexel International Corp. (United States), RealTime Software Solutions LLC (United States), BioClinica Inc. (United States), MasterControl Inc. (United States), MedNet Solutions Inc. (United States), Veeva Systems Inc. (United States), ArisGlobal LLC (United States), Cerner Corporation (United States), Athenahealth (India) and Softeq (United States). Additionally, following companies can also be profiled that are part of our coverage like Allscripts (United States) and CompuGroup (Germany). Analyst at AMA Research see United States Players to retain maximum share of Global Clinical Software market by 2026. Considering Market by End-Use Industries , the sub-segment i.e. Pharmaceutical will boost the Clinical Software market. Considering Market by Deployment, the sub-segment i.e. On-Cloud will boost the Clinical Software market. Considering Market by Delivery, the sub-segment i.e. Web-Based will boost the Clinical Software market.

Oct 6, 2021: Medidata Solution Inc. launched Medidata Sensor Cloud Network. This software is used to focus on solving challenges related to sensor integrations, standardization of sensor data, and the development of digital biomarkers and algorithms.

What Can be Explored with the Clinical Software Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Clinical Software Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Clinical Software
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Clinical Software market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Clinical Software market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Government Agency/Government, Medical Centres, Healthcare Systems, End-Use Industries and Research & Development.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Clinics
  • Medical Research Centres
  • Others
By End-Use Industries
  • Pharmaceutical
  • Biotechnology
  • Healthcare
  • Others

By Deployment
  • On-Cloud
  • On-Premises

By Delivery
  • Web-Based
  • Licensed Enterprise
  • Software as a Service (SAAS)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising prevalence of infectious, chronic, and rare diseases
      • 3.2.2. Increasing demand for remote monitoring
    • 3.3. Market Challenges
      • 3.3.1. Delays caused by disconnected systems, redundant workflows, and manual data re-entry
    • 3.4. Market Trends
      • 3.4.1. Enhance patient experience
      • 3.4.2. The rapid adoption of digital technologies
      • 3.4.3. The rapid development of new software programs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Software, by Application, End-Use Industries , Deployment, Delivery and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Clinical Software (Value)
      • 5.2.1. Global Clinical Software by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinics
        • 5.2.1.3. Medical Research Centres
        • 5.2.1.4. Others
      • 5.2.2. Global Clinical Software by: Deployment (Value)
        • 5.2.2.1. On-Cloud
        • 5.2.2.2. On-Premises
      • 5.2.3. Global Clinical Software by: Delivery (Value)
        • 5.2.3.1. Web-Based
        • 5.2.3.2. Licensed Enterprise
        • 5.2.3.3. Software as a Service (SAAS)
      • 5.2.4. Global Clinical Software Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Clinical Software (Price)
  • 6. Clinical Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medidata Solutions Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. International Machine Business Corporation (IBM) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Oracle Corporation (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Parexel International Corp. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. RealTime Software Solutions LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioClinica Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MasterControl Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MedNet Solutions Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Veeva Systems Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ArisGlobal LLC (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cerner Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Athenahealth (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Softeq (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Clinical Software Sale, by Application, End-Use Industries , Deployment, Delivery and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Clinical Software (Value)
      • 7.2.1. Global Clinical Software by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinics
        • 7.2.1.3. Medical Research Centres
        • 7.2.1.4. Others
      • 7.2.2. Global Clinical Software by: Deployment (Value)
        • 7.2.2.1. On-Cloud
        • 7.2.2.2. On-Premises
      • 7.2.3. Global Clinical Software by: Delivery (Value)
        • 7.2.3.1. Web-Based
        • 7.2.3.2. Licensed Enterprise
        • 7.2.3.3. Software as a Service (SAAS)
      • 7.2.4. Global Clinical Software Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Clinical Software (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Software: by Application(USD Million)
  • Table 2. Clinical Software Hospitals , by Region USD Million (2015-2020)
  • Table 3. Clinical Software Clinics , by Region USD Million (2015-2020)
  • Table 4. Clinical Software Medical Research Centres , by Region USD Million (2015-2020)
  • Table 5. Clinical Software Others , by Region USD Million (2015-2020)
  • Table 6. Clinical Software: by Deployment(USD Million)
  • Table 7. Clinical Software On-Cloud , by Region USD Million (2015-2020)
  • Table 8. Clinical Software On-Premises , by Region USD Million (2015-2020)
  • Table 9. Clinical Software: by Delivery(USD Million)
  • Table 10. Clinical Software Web-Based , by Region USD Million (2015-2020)
  • Table 11. Clinical Software Licensed Enterprise , by Region USD Million (2015-2020)
  • Table 12. Clinical Software Software as a Service (SAAS) , by Region USD Million (2015-2020)
  • Table 13. South America Clinical Software, by Country USD Million (2015-2020)
  • Table 14. South America Clinical Software, by Application USD Million (2015-2020)
  • Table 15. South America Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 16. South America Clinical Software, by Deployment USD Million (2015-2020)
  • Table 17. South America Clinical Software, by Delivery USD Million (2015-2020)
  • Table 18. Brazil Clinical Software, by Application USD Million (2015-2020)
  • Table 19. Brazil Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 20. Brazil Clinical Software, by Deployment USD Million (2015-2020)
  • Table 21. Brazil Clinical Software, by Delivery USD Million (2015-2020)
  • Table 22. Argentina Clinical Software, by Application USD Million (2015-2020)
  • Table 23. Argentina Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 24. Argentina Clinical Software, by Deployment USD Million (2015-2020)
  • Table 25. Argentina Clinical Software, by Delivery USD Million (2015-2020)
  • Table 26. Rest of South America Clinical Software, by Application USD Million (2015-2020)
  • Table 27. Rest of South America Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 28. Rest of South America Clinical Software, by Deployment USD Million (2015-2020)
  • Table 29. Rest of South America Clinical Software, by Delivery USD Million (2015-2020)
  • Table 30. Asia Pacific Clinical Software, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Clinical Software, by Application USD Million (2015-2020)
  • Table 32. Asia Pacific Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 33. Asia Pacific Clinical Software, by Deployment USD Million (2015-2020)
  • Table 34. Asia Pacific Clinical Software, by Delivery USD Million (2015-2020)
  • Table 35. China Clinical Software, by Application USD Million (2015-2020)
  • Table 36. China Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 37. China Clinical Software, by Deployment USD Million (2015-2020)
  • Table 38. China Clinical Software, by Delivery USD Million (2015-2020)
  • Table 39. Japan Clinical Software, by Application USD Million (2015-2020)
  • Table 40. Japan Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 41. Japan Clinical Software, by Deployment USD Million (2015-2020)
  • Table 42. Japan Clinical Software, by Delivery USD Million (2015-2020)
  • Table 43. India Clinical Software, by Application USD Million (2015-2020)
  • Table 44. India Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 45. India Clinical Software, by Deployment USD Million (2015-2020)
  • Table 46. India Clinical Software, by Delivery USD Million (2015-2020)
  • Table 47. South Korea Clinical Software, by Application USD Million (2015-2020)
  • Table 48. South Korea Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 49. South Korea Clinical Software, by Deployment USD Million (2015-2020)
  • Table 50. South Korea Clinical Software, by Delivery USD Million (2015-2020)
  • Table 51. Taiwan Clinical Software, by Application USD Million (2015-2020)
  • Table 52. Taiwan Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 53. Taiwan Clinical Software, by Deployment USD Million (2015-2020)
  • Table 54. Taiwan Clinical Software, by Delivery USD Million (2015-2020)
  • Table 55. Australia Clinical Software, by Application USD Million (2015-2020)
  • Table 56. Australia Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 57. Australia Clinical Software, by Deployment USD Million (2015-2020)
  • Table 58. Australia Clinical Software, by Delivery USD Million (2015-2020)
  • Table 59. Rest of Asia-Pacific Clinical Software, by Application USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Clinical Software, by Deployment USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Clinical Software, by Delivery USD Million (2015-2020)
  • Table 63. Europe Clinical Software, by Country USD Million (2015-2020)
  • Table 64. Europe Clinical Software, by Application USD Million (2015-2020)
  • Table 65. Europe Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 66. Europe Clinical Software, by Deployment USD Million (2015-2020)
  • Table 67. Europe Clinical Software, by Delivery USD Million (2015-2020)
  • Table 68. Germany Clinical Software, by Application USD Million (2015-2020)
  • Table 69. Germany Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 70. Germany Clinical Software, by Deployment USD Million (2015-2020)
  • Table 71. Germany Clinical Software, by Delivery USD Million (2015-2020)
  • Table 72. France Clinical Software, by Application USD Million (2015-2020)
  • Table 73. France Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 74. France Clinical Software, by Deployment USD Million (2015-2020)
  • Table 75. France Clinical Software, by Delivery USD Million (2015-2020)
  • Table 76. Italy Clinical Software, by Application USD Million (2015-2020)
  • Table 77. Italy Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 78. Italy Clinical Software, by Deployment USD Million (2015-2020)
  • Table 79. Italy Clinical Software, by Delivery USD Million (2015-2020)
  • Table 80. United Kingdom Clinical Software, by Application USD Million (2015-2020)
  • Table 81. United Kingdom Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 82. United Kingdom Clinical Software, by Deployment USD Million (2015-2020)
  • Table 83. United Kingdom Clinical Software, by Delivery USD Million (2015-2020)
  • Table 84. Netherlands Clinical Software, by Application USD Million (2015-2020)
  • Table 85. Netherlands Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 86. Netherlands Clinical Software, by Deployment USD Million (2015-2020)
  • Table 87. Netherlands Clinical Software, by Delivery USD Million (2015-2020)
  • Table 88. Rest of Europe Clinical Software, by Application USD Million (2015-2020)
  • Table 89. Rest of Europe Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 90. Rest of Europe Clinical Software, by Deployment USD Million (2015-2020)
  • Table 91. Rest of Europe Clinical Software, by Delivery USD Million (2015-2020)
  • Table 92. MEA Clinical Software, by Country USD Million (2015-2020)
  • Table 93. MEA Clinical Software, by Application USD Million (2015-2020)
  • Table 94. MEA Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 95. MEA Clinical Software, by Deployment USD Million (2015-2020)
  • Table 96. MEA Clinical Software, by Delivery USD Million (2015-2020)
  • Table 97. Middle East Clinical Software, by Application USD Million (2015-2020)
  • Table 98. Middle East Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 99. Middle East Clinical Software, by Deployment USD Million (2015-2020)
  • Table 100. Middle East Clinical Software, by Delivery USD Million (2015-2020)
  • Table 101. Africa Clinical Software, by Application USD Million (2015-2020)
  • Table 102. Africa Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 103. Africa Clinical Software, by Deployment USD Million (2015-2020)
  • Table 104. Africa Clinical Software, by Delivery USD Million (2015-2020)
  • Table 105. North America Clinical Software, by Country USD Million (2015-2020)
  • Table 106. North America Clinical Software, by Application USD Million (2015-2020)
  • Table 107. North America Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 108. North America Clinical Software, by Deployment USD Million (2015-2020)
  • Table 109. North America Clinical Software, by Delivery USD Million (2015-2020)
  • Table 110. United States Clinical Software, by Application USD Million (2015-2020)
  • Table 111. United States Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 112. United States Clinical Software, by Deployment USD Million (2015-2020)
  • Table 113. United States Clinical Software, by Delivery USD Million (2015-2020)
  • Table 114. Canada Clinical Software, by Application USD Million (2015-2020)
  • Table 115. Canada Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 116. Canada Clinical Software, by Deployment USD Million (2015-2020)
  • Table 117. Canada Clinical Software, by Delivery USD Million (2015-2020)
  • Table 118. Mexico Clinical Software, by Application USD Million (2015-2020)
  • Table 119. Mexico Clinical Software, by End-Use Industries USD Million (2015-2020)
  • Table 120. Mexico Clinical Software, by Deployment USD Million (2015-2020)
  • Table 121. Mexico Clinical Software, by Delivery USD Million (2015-2020)
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Clinical Software: by Application(USD Million)
  • Table 136. Clinical Software Hospitals , by Region USD Million (2021-2026)
  • Table 137. Clinical Software Clinics , by Region USD Million (2021-2026)
  • Table 138. Clinical Software Medical Research Centres , by Region USD Million (2021-2026)
  • Table 139. Clinical Software Others , by Region USD Million (2021-2026)
  • Table 140. Clinical Software: by Deployment(USD Million)
  • Table 141. Clinical Software On-Cloud , by Region USD Million (2021-2026)
  • Table 142. Clinical Software On-Premises , by Region USD Million (2021-2026)
  • Table 143. Clinical Software: by Delivery(USD Million)
  • Table 144. Clinical Software Web-Based , by Region USD Million (2021-2026)
  • Table 145. Clinical Software Licensed Enterprise , by Region USD Million (2021-2026)
  • Table 146. Clinical Software Software as a Service (SAAS) , by Region USD Million (2021-2026)
  • Table 147. South America Clinical Software, by Country USD Million (2021-2026)
  • Table 148. South America Clinical Software, by Application USD Million (2021-2026)
  • Table 149. South America Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 150. South America Clinical Software, by Deployment USD Million (2021-2026)
  • Table 151. South America Clinical Software, by Delivery USD Million (2021-2026)
  • Table 152. Brazil Clinical Software, by Application USD Million (2021-2026)
  • Table 153. Brazil Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 154. Brazil Clinical Software, by Deployment USD Million (2021-2026)
  • Table 155. Brazil Clinical Software, by Delivery USD Million (2021-2026)
  • Table 156. Argentina Clinical Software, by Application USD Million (2021-2026)
  • Table 157. Argentina Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 158. Argentina Clinical Software, by Deployment USD Million (2021-2026)
  • Table 159. Argentina Clinical Software, by Delivery USD Million (2021-2026)
  • Table 160. Rest of South America Clinical Software, by Application USD Million (2021-2026)
  • Table 161. Rest of South America Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 162. Rest of South America Clinical Software, by Deployment USD Million (2021-2026)
  • Table 163. Rest of South America Clinical Software, by Delivery USD Million (2021-2026)
  • Table 164. Asia Pacific Clinical Software, by Country USD Million (2021-2026)
  • Table 165. Asia Pacific Clinical Software, by Application USD Million (2021-2026)
  • Table 166. Asia Pacific Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 167. Asia Pacific Clinical Software, by Deployment USD Million (2021-2026)
  • Table 168. Asia Pacific Clinical Software, by Delivery USD Million (2021-2026)
  • Table 169. China Clinical Software, by Application USD Million (2021-2026)
  • Table 170. China Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 171. China Clinical Software, by Deployment USD Million (2021-2026)
  • Table 172. China Clinical Software, by Delivery USD Million (2021-2026)
  • Table 173. Japan Clinical Software, by Application USD Million (2021-2026)
  • Table 174. Japan Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 175. Japan Clinical Software, by Deployment USD Million (2021-2026)
  • Table 176. Japan Clinical Software, by Delivery USD Million (2021-2026)
  • Table 177. India Clinical Software, by Application USD Million (2021-2026)
  • Table 178. India Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 179. India Clinical Software, by Deployment USD Million (2021-2026)
  • Table 180. India Clinical Software, by Delivery USD Million (2021-2026)
  • Table 181. South Korea Clinical Software, by Application USD Million (2021-2026)
  • Table 182. South Korea Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 183. South Korea Clinical Software, by Deployment USD Million (2021-2026)
  • Table 184. South Korea Clinical Software, by Delivery USD Million (2021-2026)
  • Table 185. Taiwan Clinical Software, by Application USD Million (2021-2026)
  • Table 186. Taiwan Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 187. Taiwan Clinical Software, by Deployment USD Million (2021-2026)
  • Table 188. Taiwan Clinical Software, by Delivery USD Million (2021-2026)
  • Table 189. Australia Clinical Software, by Application USD Million (2021-2026)
  • Table 190. Australia Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 191. Australia Clinical Software, by Deployment USD Million (2021-2026)
  • Table 192. Australia Clinical Software, by Delivery USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Clinical Software, by Application USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 195. Rest of Asia-Pacific Clinical Software, by Deployment USD Million (2021-2026)
  • Table 196. Rest of Asia-Pacific Clinical Software, by Delivery USD Million (2021-2026)
  • Table 197. Europe Clinical Software, by Country USD Million (2021-2026)
  • Table 198. Europe Clinical Software, by Application USD Million (2021-2026)
  • Table 199. Europe Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 200. Europe Clinical Software, by Deployment USD Million (2021-2026)
  • Table 201. Europe Clinical Software, by Delivery USD Million (2021-2026)
  • Table 202. Germany Clinical Software, by Application USD Million (2021-2026)
  • Table 203. Germany Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 204. Germany Clinical Software, by Deployment USD Million (2021-2026)
  • Table 205. Germany Clinical Software, by Delivery USD Million (2021-2026)
  • Table 206. France Clinical Software, by Application USD Million (2021-2026)
  • Table 207. France Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 208. France Clinical Software, by Deployment USD Million (2021-2026)
  • Table 209. France Clinical Software, by Delivery USD Million (2021-2026)
  • Table 210. Italy Clinical Software, by Application USD Million (2021-2026)
  • Table 211. Italy Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 212. Italy Clinical Software, by Deployment USD Million (2021-2026)
  • Table 213. Italy Clinical Software, by Delivery USD Million (2021-2026)
  • Table 214. United Kingdom Clinical Software, by Application USD Million (2021-2026)
  • Table 215. United Kingdom Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 216. United Kingdom Clinical Software, by Deployment USD Million (2021-2026)
  • Table 217. United Kingdom Clinical Software, by Delivery USD Million (2021-2026)
  • Table 218. Netherlands Clinical Software, by Application USD Million (2021-2026)
  • Table 219. Netherlands Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 220. Netherlands Clinical Software, by Deployment USD Million (2021-2026)
  • Table 221. Netherlands Clinical Software, by Delivery USD Million (2021-2026)
  • Table 222. Rest of Europe Clinical Software, by Application USD Million (2021-2026)
  • Table 223. Rest of Europe Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 224. Rest of Europe Clinical Software, by Deployment USD Million (2021-2026)
  • Table 225. Rest of Europe Clinical Software, by Delivery USD Million (2021-2026)
  • Table 226. MEA Clinical Software, by Country USD Million (2021-2026)
  • Table 227. MEA Clinical Software, by Application USD Million (2021-2026)
  • Table 228. MEA Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 229. MEA Clinical Software, by Deployment USD Million (2021-2026)
  • Table 230. MEA Clinical Software, by Delivery USD Million (2021-2026)
  • Table 231. Middle East Clinical Software, by Application USD Million (2021-2026)
  • Table 232. Middle East Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 233. Middle East Clinical Software, by Deployment USD Million (2021-2026)
  • Table 234. Middle East Clinical Software, by Delivery USD Million (2021-2026)
  • Table 235. Africa Clinical Software, by Application USD Million (2021-2026)
  • Table 236. Africa Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 237. Africa Clinical Software, by Deployment USD Million (2021-2026)
  • Table 238. Africa Clinical Software, by Delivery USD Million (2021-2026)
  • Table 239. North America Clinical Software, by Country USD Million (2021-2026)
  • Table 240. North America Clinical Software, by Application USD Million (2021-2026)
  • Table 241. North America Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 242. North America Clinical Software, by Deployment USD Million (2021-2026)
  • Table 243. North America Clinical Software, by Delivery USD Million (2021-2026)
  • Table 244. United States Clinical Software, by Application USD Million (2021-2026)
  • Table 245. United States Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 246. United States Clinical Software, by Deployment USD Million (2021-2026)
  • Table 247. United States Clinical Software, by Delivery USD Million (2021-2026)
  • Table 248. Canada Clinical Software, by Application USD Million (2021-2026)
  • Table 249. Canada Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 250. Canada Clinical Software, by Deployment USD Million (2021-2026)
  • Table 251. Canada Clinical Software, by Delivery USD Million (2021-2026)
  • Table 252. Mexico Clinical Software, by Application USD Million (2021-2026)
  • Table 253. Mexico Clinical Software, by End-Use Industries USD Million (2021-2026)
  • Table 254. Mexico Clinical Software, by Deployment USD Million (2021-2026)
  • Table 255. Mexico Clinical Software, by Delivery USD Million (2021-2026)
  • Table 256. Research Programs/Design for This Report
  • Table 257. Key Data Information from Secondary Sources
  • Table 258. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Software: by Application USD Million (2015-2020)
  • Figure 5. Global Clinical Software: by Deployment USD Million (2015-2020)
  • Figure 6. Global Clinical Software: by Delivery USD Million (2015-2020)
  • Figure 7. South America Clinical Software Share (%), by Country
  • Figure 8. Asia Pacific Clinical Software Share (%), by Country
  • Figure 9. Europe Clinical Software Share (%), by Country
  • Figure 10. MEA Clinical Software Share (%), by Country
  • Figure 11. North America Clinical Software Share (%), by Country
  • Figure 12. Global Clinical Software share by Players 2020 (%)
  • Figure 13. Global Clinical Software share by Players (Top 3) 2020(%)
  • Figure 14. Global Clinical Software share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Medidata Solutions Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Medidata Solutions Inc. (United States) Revenue: by Geography 2020
  • Figure 18. International Machine Business Corporation (IBM) (United States) Revenue, Net Income and Gross profit
  • Figure 19. International Machine Business Corporation (IBM) (United States) Revenue: by Geography 2020
  • Figure 20. Oracle Corporation (India) Revenue, Net Income and Gross profit
  • Figure 21. Oracle Corporation (India) Revenue: by Geography 2020
  • Figure 22. Parexel International Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Parexel International Corp. (United States) Revenue: by Geography 2020
  • Figure 24. RealTime Software Solutions LLC (United States) Revenue, Net Income and Gross profit
  • Figure 25. RealTime Software Solutions LLC (United States) Revenue: by Geography 2020
  • Figure 26. BioClinica Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. BioClinica Inc. (United States) Revenue: by Geography 2020
  • Figure 28. MasterControl Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. MasterControl Inc. (United States) Revenue: by Geography 2020
  • Figure 30. MedNet Solutions Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. MedNet Solutions Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Veeva Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Veeva Systems Inc. (United States) Revenue: by Geography 2020
  • Figure 34. ArisGlobal LLC (United States) Revenue, Net Income and Gross profit
  • Figure 35. ArisGlobal LLC (United States) Revenue: by Geography 2020
  • Figure 36. Cerner Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 37. Cerner Corporation (United States) Revenue: by Geography 2020
  • Figure 38. Athenahealth (India) Revenue, Net Income and Gross profit
  • Figure 39. Athenahealth (India) Revenue: by Geography 2020
  • Figure 40. Softeq (United States) Revenue, Net Income and Gross profit
  • Figure 41. Softeq (United States) Revenue: by Geography 2020
  • Figure 42. Global Clinical Software: by Application USD Million (2021-2026)
  • Figure 43. Global Clinical Software: by Deployment USD Million (2021-2026)
  • Figure 44. Global Clinical Software: by Delivery USD Million (2021-2026)
  • Figure 45. South America Clinical Software Share (%), by Country
  • Figure 46. Asia Pacific Clinical Software Share (%), by Country
  • Figure 47. Europe Clinical Software Share (%), by Country
  • Figure 48. MEA Clinical Software Share (%), by Country
  • Figure 49. North America Clinical Software Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medidata Solutions Inc. (United States)
  • International Machine Business Corporation (IBM) (United States)
  • Oracle Corporation (India)
  • Parexel International Corp. (United States)
  • RealTime Software Solutions LLC (United States)
  • BioClinica Inc. (United States)
  • MasterControl Inc. (United States)
  • MedNet Solutions Inc. (United States)
  • Veeva Systems Inc. (United States)
  • ArisGlobal LLC (United States)
  • Cerner Corporation (United States)
  • Athenahealth (India)
  • Softeq (United States)
Additional players considered in the study are as follows:
Allscripts (United States) , CompuGroup (Germany)
Select User Access Type

Key Highlights of Report


Oct 2021 212 Pages 69 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Clinical Software Market Quantitative research analysis
Global Clinical Software Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Clinical Software market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Clinical Software market are Medidata Solutions Inc. (United States), International Machine Business Corporation (IBM) (United States), Oracle Corporation (India), Parexel International Corp. (United States), RealTime Software Solutions LLC (United States), BioClinica Inc. (United States), MasterControl Inc. (United States), MedNet Solutions Inc. (United States), Veeva Systems Inc. (United States), ArisGlobal LLC (United States), Cerner Corporation (United States), Athenahealth (India) and Softeq (United States), to name a few.
"Enhance patient experience " is seen as one of major influencing trends for Clinical Software Market during projected period 2020-2026.

Know More About Global Clinical Software Market Report?

Have a Query? Click Here

Other Related Reports

Medical Bionics Comprehensive Study by Type (Ear Bionics, Orthopaedic Bionics, Vision Bionics, Neural /Brain Bionics, Heart Bionics), Application (Implantable, Externally Worn), Technology (Electroni...
$ 3450
Virtual Clinical Trials Comprehensive Study by Application (Oncology, Cardiovascular Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Others), Design (Interventional, Observa...
$ 3800
Triage System Comprehensive Study by Solution (Triage Platforms / Applications, Services (Digital Triage Services, Telephonic Triage Services)), End User (Primary Care Centers, Emergency / Urgent Car...
$ 3500
Custom-Compounded Therapy Comprehensive Study by Application (Paediatric, Adult, Geriatric, Veterinary), Distribution Channel (Hospital pharmacy, Compounding pharmacy, Others), Therapeutic Area (Horm...
$ 3450
Health and Beauty Retailing Comprehensive Study by Type (Vegan, Organic, Inorganic), Distribution Channel (Online, Offline), Product (Skincare/Sun Care, Hair Care, Makeup and Color Cosmetic Products,...
$ 3450
Reperfusion Treatment Comprehensive Study by End users (Hospitals, Ambulatory surgery centers, Others), Treatment (Cyclosporin, Stem Cell Therapy, Therapeutic Hypothermia, Hydrogen Sulfide treatment,...
$ 3450